IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.

TSXV:IBT - Post by User

IBEX Technologies Inc

<< Previous

Bullboard Posts

Next >>

Post by guarantor1on Apr 10, 2021 3:52pm

134 Views

Post# 32973136

So. IBT is at 35 cents 15 yr High. How do the Numbers Look

I am seeing about 17 cents cash, and that isn't bad
So trading at 2x cash is good,
And when you take away cash from the equatton,
With No Debt,
You have an Enterprise Value of 17 cents per share,
That is generatring $4 or $5 M in Sales,
Or about 3x sales;
Which is good. imo

<< Previous

Bullboard Posts

Next >>

2024, a breakthrough year for silver